http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1235659-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0eb300f8bb645d8c16e83b2fd3abb9cd |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-30 |
| filingDate | 1984-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1988-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_260f9b89f2f26f018fffad17b0a47420 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91d37c0703374749ab785d65cd45a6f9 |
| publicationDate | 1988-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-1235659-A |
| titleOfInvention | Pharmaceutical compositions and method for preparing phosphatidylserine compositions useful in treating central nervous system disorders without effects on blood coagulation |
| abstract | ABSTRACT OF THE DISCLOSURE Processes are provided herein for the preparation of phospholipid compositions comprised of a mixture of phosphatidylserine and phosphatidyl-ethanolamine in a specified ratio. Such compositions have activity against disorders of the central nervous system but without secondary haematic coagulation effects. Particularly useful synergistic compositions comprise from 60 to 75% by weight of phosphatidylserine and from 40 to 25% by weight of phosphatidylethanolamine. |
| priorityDate | 1984-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 112.